Literature DB >> 26961863

AGEs and HMGB1 Increase Inflammatory Cytokine Production from Human Placental Cells, Resulting in an Enhancement of Monocyte Migration.

Koumei Shirasuna1, Kotomi Seno1, Ayaka Ohtsu1, Shogo Shiratsuki1, Akihide Ohkuchi2, Hirotada Suzuki2, Shigeki Matsubara2, Shiho Nagayama2, Hisataka Iwata1, Takehito Kuwayama1.   

Abstract

PROBLEM: Advanced glycation end products (AGEs) and high-mobility group box-1 (HMGB1) are considered contributing to placental inflammation. We examined the effect of AGEs and HMGB1 on cytokines from Sw.71 human trophoblast cell lines and the interactions between Sw.71 cells and THP-1-monocytes. METHODS OF STUDY: Sw.71 cells were cultured with/without AGEs or HMGB1. We examined the role of AGEs or HMGB1 on THP1 migration and effect of AGEs on IL-6 from Sw.71 cells using co-cultures or conditioned medium from THP-1 cells.
RESULTS: AGEs and HMGB1 increased interleukin (IL)-6, IL-8, and chemokine C-C motif ligand 2 (CCL2) secretion from Sw.71 cells. The secretion of IL-6 was dependent on reactive oxygen species (ROS) and NF-κB. AGEs stimulated IL-6 secretion through receptor RAGE and TLR4, whereas HMGB1 stimulated it through TLR4. AGEs, but not HMGB1, increased monocyte migration via IL-8 and CCL2 from Sw.71 cells. THP-1 monocytes induced IL-6 secretion from Sw.71 cells, and AGEs further stimulated it.
CONCLUSIONS: AGEs and HMGB1 may promote sterile placental inflammation cooperating with monocytes/macrophages.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  advanced glycation end products; high-mobility group box-1; inflammation; placenta

Mesh:

Substances:

Year:  2016        PMID: 26961863     DOI: 10.1111/aji.12506

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  9 in total

Review 1.  Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.

Authors:  Frank T Spradley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

Review 2.  RAGE against the Machine: Can Increasing Our Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in Pregnancy?

Authors:  Courtney K Kurashima; Po'okela K Ng; Claire E Kendal-Wright
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

3.  Advanced glycation end products and lipopolysaccharides stimulate interleukin-6 secretion via the RAGE/TLR4-NF-κB-ROS pathways and resveratrol attenuates these inflammatory responses in mouse macrophages.

Authors:  Ayaka Ohtsu; Yui Shibutani; Kotomi Seno; Hisataka Iwata; Takehito Kuwayama; Koumei Shirasuna
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

4.  Antiphospholipid Antibodies Inhibit Trophoblast Toll-Like Receptor and Inflammasome Negative Regulators.

Authors:  Melissa J Mulla; Ingrid C Weel; Julie A Potter; Stefan M Gysler; Jane E Salmon; Maria T S Peraçoli; Carla V Rothlin; Lawrence W Chamley; Vikki M Abrahams
Journal:  Arthritis Rheumatol       Date:  2018-04-25       Impact factor: 10.995

5.  Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.

Authors:  Kayoko Waki; Kouichiro Kawano; Naotake Tsuda; Kimio Ushijima; Kyogo Itoh; Akira Yamada
Journal:  J Immunol Res       Date:  2017-04-27       Impact factor: 4.818

6.  Aggregation of Human Trophoblast Cells into Three-Dimensional Culture System Enhances Anti-Inflammatory Characteristics through Cytoskeleton Regulation.

Authors:  Kotomi Seno; Yasuhisa Munakata; Michiya Sano; Ryouka Kawahara-Miki; Hironori Takahashi; Akihide Ohkuchi; Hisataka Iwata; Takehito Kuwayama; Koumei Shirasuna
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

Review 7.  Role of the NLRP3 Inflammasome in Preeclampsia.

Authors:  Koumei Shirasuna; Tadayoshi Karasawa; Masafumi Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-25       Impact factor: 5.555

Review 8.  High-mobility group box 1 is a driver of inflammation throughout pregnancy.

Authors:  Chelsea A Saito Reis; Justin G Padron; Nainoa D Norman Ing; Claire E Kendal-Wright
Journal:  Am J Reprod Immunol       Date:  2020-09-17       Impact factor: 3.886

9.  Advanced glycation end products regulate interleukin-1β production in human placenta.

Authors:  Kotomi Seno; Saoko Sase; Ayae Ozeki; Hironori Takahashi; Akihide Ohkuchi; Hirotada Suzuki; Shigeki Matsubara; Hisataka Iwata; Takehito Kuwayama; Koumei Shirasuna
Journal:  J Reprod Dev       Date:  2017-05-18       Impact factor: 2.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.